Back to trial details

Intake questionnaire

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Applying to Vanderbilt University/Ingram Cancer Center · Nashville, Tennessee

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Anatomic Stage I Breast Cancer?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Nashville for study visits?